Hypothyroidism treatment with better quality of life
Numerous top thyroidologists have recognized that not everyone does well on thyroid hormone therapy, particularly after thyroidectomy. Even on appropriate thyroid hormone therapy, 1 in 6 optimally treated patients experience long-term fatigue, "brain fog," and other symptoms detrimental to quality of life.
Atyra Bio was founded by a thyroid cancer patient, galvanized by her challenging experiences with thyroid replacement meds post-thyroidectomy, seeking to empower endocrinologists and patients alike.
By developing a new drug formulation and a companion gene test, we aim to avert misdirected healthcare and to make life better for users of levothyroxine, a drug dispensed over 100 million times each year.
The problem is pressing, our goal is audacious, and yet thanks to the exciting state of the art today, it is solvable. Pre-seed stage, we are conducting lean, low-burn-rate R&D, leveraging patient volunteers, friends and family funding, and science-as-a-service. Stay tuned!
Atyra Bio was founded by a thyroid cancer patient, galvanized by her challenging experiences with thyroid replacement meds post-thyroidectomy, seeking to empower endocrinologists and patients alike.
By developing a new drug formulation and a companion gene test, we aim to avert misdirected healthcare and to make life better for users of levothyroxine, a drug dispensed over 100 million times each year.
The problem is pressing, our goal is audacious, and yet thanks to the exciting state of the art today, it is solvable. Pre-seed stage, we are conducting lean, low-burn-rate R&D, leveraging patient volunteers, friends and family funding, and science-as-a-service. Stay tuned!